ClinicalTrials.gg
RecruitingNCT04900168IPMMTBIUpdated Nov 6, 2026

Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury

An observational study in Moderate Traumatic Brain Injury, sponsored by Tang-Du Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Tang-Du Hospital · Observational

How we know

From the registry’s dates

  • Started Jun 2021; still recruiting 5 years 5 months later.
Updated Nov 6, 2026Primary completion movedStudy completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Brain Injuries, Traumatic with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Brain Injuries, Traumatic · China.

Planned enrollment
2nd of 34
1,000 · median 110
Started
2021
with 3 others
Observational
34 of 60
19 open now
Primary completion
2026-12
later than 16 of 29 live
Registered
20th of 60
by date
Lead sponsor
6 of 60
Tang-Du Hospital

Among the 60 studies in Brain Injuries, Traumatic with a site in China, this one is the 2nd largest by planned enrollment of the 34 observational ones that give a count, is one of 4 that started in 2021, is one of 34 observational ones, reaches primary completion later than 16 of the 29 other live ones, and was the 20th registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

29 of the 60 studies in Brain Injuries, Traumatic with a site in China are open now. Recruiting first, the newest first:

24 more — sign in →

All 29 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Brain Injuries, Traumatic with a site in China, or all of them as a file.
02

Study summary

Objectives The primary focus for scientific investigation is to conduct a multi-center observational study to determine if intracranial pressure (ICP) monitoring to direct treatment of patients with moderate traumatic brain injury (TBI) improves medical practice and patient outcomes in China.

Design and Outcomes This is a prospective observational cohort multi-center study with blinded evaluation of outcome. Neurologic outcome is evaluated by extended Glasgow outcome score(GOSE) at 6 months.

Interventions and Duration This is an observational study. The decision of intracranial pressure monitoring is made by the relatives of patient. Management of all patients will be consistent with protocols presently being used in the study hospitals. For patients who received ICP monitoring, the management will also be based specifically on the presence of intracranial hypertension.

Sample Size and Population Sample size calculation: Not applicable. The sample size will be equal to the total number of moderate trumatic brain injury patients consecutively admitted to hospitals during the study period.

03

Conditions studied

  • Moderate Traumatic Brain Injury

Keywords

  • Intracranial Pressure
04

Who can participate

The criteria were revised on the registry on Nov 6, 2026. See what changed

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patient with acute moderate traumatic brain injury

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • History of head trauma
  • 18 ≤ age ≤ 75 years
  • Abnormal head CT scan (skull fracture, intracranial hematoma, brain contusion, cerebral infarction, brain edema, hydrocephalus, etc.)
  • Glasgow coma scale at admission: 9-13
  • No pregnant

Exclusion criteria

Exclusion Criteria:

  • Refusing follow up visit
  • Surgical treatment in other hospital before admission
  • Consciousness disorder caused not by head trauma (alcoholism, drug overdose, etc.)
  • Estimated survival time less than 1 year
  • Participating in other on-going clinical researches
  • Other systemic diseases: uremia, liver cirrhosis, malignant tumor, mental illness, drug, or alcohol dependence, etc.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • all patients with moderate traumatic brain injury
06

What researchers measure

Primary outcomes

  1. Good neurologic outcome

    The proportion of patients with good neurological outcomes (GOSE: 5-8) in each group at 6 months after traumatic brain injury

    Time frame: Within 6 months after traumatic brain injury

Secondary outcomes

  1. 6 months mortality

    The mortality of patients in each group at 6 months after traumatic brain injury

    Time frame: Within 6 months after traumatic brain injury

  2. In-hospital mortality

    The mortality of patients in each group during hospitalization

    Time frame: Within 1 month after traumatic brain injury

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Godoy DA, Rubiano A, Rabinstein AA, Bullock R, Sahuquillo J. Moderate Traumatic Brain Injury: The Grey Zone of Neurotrauma. Neurocrit Care. 2016 Oct;25(2):306-19. doi: 10.1007/s12028-016-0253-y. PubMed 26927279 ↗
  • Hawryluk GW, Manley GT. Classification of traumatic brain injury: past, present, and future. Handb Clin Neurol. 2015;127:15-21. doi: 10.1016/B978-0-444-52892-6.00002-7. PubMed 25702207 ↗
  • Stocchetti N, Carbonara M, Citerio G, Ercole A, Skrifvars MB, Smielewski P, Zoerle T, Menon DK. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017 Jun;16(6):452-464. doi: 10.1016/S1474-4422(17)30118-7. PubMed 28504109 ↗
  • Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N, Rubiano AM, Shutter L, Tasker RC, Vavilala MS, Wilberger J, Wright DW, Ghajar J. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017 Jan 1;80(1):6-15. doi: 10.1227/NEU.0000000000001432. PubMed 27654000 ↗
  • Watanitanon A, Lyons VH, Lele AV, Krishnamoorthy V, Chaikittisilpa N, Chandee T, Vavilala MS. Clinical Epidemiology of Adults With Moderate Traumatic Brain Injury. Crit Care Med. 2018 May;46(5):781-787. doi: 10.1097/CCM.0000000000002991. PubMed 29369057 ↗
  • Lobato RD, Rivas JJ, Gomez PA, Castaneda M, Canizal JM, Sarabia R, Cabrera A, Munoz MJ. Head-injured patients who talk and deteriorate into coma. Analysis of 211 cases studied with computerized tomography. J Neurosurg. 1991 Aug;75(2):256-61. doi: 10.3171/jns.1991.75.2.0256. PubMed 2072163 ↗
  • Peterson EC, Chesnut RM. Talk and die revisited: bifrontal contusions and late deterioration. J Trauma. 2011 Dec;71(6):1588-92. doi: 10.1097/TA.0b013e31822b791d. PubMed 22182868 ↗
  • Compagnone C, d'Avella D, Servadei F, Angileri FF, Brambilla G, Conti C, Cristofori L, Delfini R, Denaro L, Ducati A, Gaini SM, Stefini R, Tomei G, Tagliaferri F, Trincia G, Tomasello F. Patients with moderate head injury: a prospective multicenter study of 315 patients. Neurosurgery. 2009 Apr;64(4):690-6; discussion 696-7. doi: 10.1227/01.NEU.0000340796.18738.F7. PubMed 19197220 ↗
  • Balestreri M, Czosnyka M, Hutchinson P, Steiner LA, Hiler M, Smielewski P, Pickard JD. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocrit Care. 2006;4(1):8-13. doi: 10.1385/NCC:4:1:008. PubMed 16498188 ↗
  • Juul N, Morris GF, Marshall SB, Marshall LF. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg. 2000 Jan;92(1):1-6. doi: 10.3171/jns.2000.92.1.0001. PubMed 10616075 ↗
  • Harary M, Dolmans RGF, Gormley WB. Intracranial Pressure Monitoring-Review and Avenues for Development. Sensors (Basel). 2018 Feb 5;18(2):465. doi: 10.3390/s18020465. PubMed 29401746 ↗
  • Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth. 2006 Jul;97(1):26-38. doi: 10.1093/bja/ael110. Epub 2006 May 12. PubMed 16698860 ↗
  • Leinonen V, Vanninen R, Rauramaa T. Raised intracranial pressure and brain edema. Handb Clin Neurol. 2017;145:25-37. doi: 10.1016/B978-0-12-802395-2.00004-3. PubMed 28987174 ↗
  • Muballe KD, Sewani-Rusike CR, Longo-Mbenza B, Iputo J. Predictors of recovery in moderate to severe traumatic brain injury. J Neurosurg. 2018 Nov 9;131(5):1648-1657. doi: 10.3171/2018.4.JNS172185. Print 2019 Nov 1. PubMed 30497133 ↗
  • Li Z, Xu F, Li Y, Wang R, Zhang Z, Qu Y. Assessment of intracranial pressure monitoring in patients with moderate traumatic brain injury: A retrospective cohort study. Clin Neurol Neurosurg. 2020 Feb;189:105538. doi: 10.1016/j.clineuro.2019.105538. Epub 2019 Oct 31. PubMed 31846845 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2021 (actual). Primary completion is estimated for Dec 2026, 66 months after the start.

Of 231 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 95. This study's planned 66 months is above that.

Counting every sponsor, half of 253 studies reached it within 49 months; a quarter within 23 and three quarters within 95.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Dec 2023 → Dec 2026 and completion Jun 2024 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2021
First posted
May 25, 2021
StartActual
Jun 1, 2021
Primary completionEst.
Dec 31, 2026was Dec 2023
CompletionEst.
Jun 30, 2027was Jun 2024
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 31, 2023→Dec 31, 2026
Nov 6, 2026
Study completion
Jun 30, 2024→Jun 30, 2027
Nov 6, 2026
Enrollment
832→1000
Nov 6, 2026
Eligibility
2 inclusion criteria edited, 2 removed; 9 exclusion criteria removed
What changed in the criteria
Inclusion criteria
  • Edited18 ≤ age ≤ 7075 years
  • EditedGlasgow coma scale at admission: 9-1213
  • RemovedArriving at hospital within 24 hours after injury
  • RemovedSystolic blood pressure ≥100 millimeter of mercury
Exclusion criteria
  • RemovedPenetrating head injury, spine or spinal cord injury
  • RemovedCardiopulmonary resuscitation after injury or in need of blood transfusion due to active bleeding
  • RemovedPrior history of head trauma or stroke
  • RemovedMultiple injuries, with severity score of other parts>18
  • RemovedRhabdomyolysis, with blood creatine kinase (CK)>5000 international unit/L
  • RemovedInjury of aorta, carotid artery or vertebral artery
  • RemovedSerum creatinine (female)>1.2mg/dL (106μmol/L), serum creatinine (male)>1.5mg/dL (133μmol/L)
  • RemovedGlomerular filtration rate (eGFR) <60 milliliter/min
  • RemovedBody mass index (BMI) <18.5kg/m2 or >40kg/m2
Nov 6, 2026
Interventions
Arms added: all patients with moderate traumatic brain injury; arms removed: ICP monitoring group·conventional treatment group
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Primary completion Dec 31, 2023→Dec 31, 2026
    Study completion Jun 30, 2024→Jun 30, 2027
    Enrollment 832→1000
    Eligibility 2 inclusion criteria edited, 2 removed; 9 exclusion criteria removed
    What changed in the criteria
    Inclusion criteria
    • Edited18 ≤ age ≤ 7075 years
    • EditedGlasgow coma scale at admission: 9-1213
    • RemovedArriving at hospital within 24 hours after injury
    • RemovedSystolic blood pressure ≥100 millimeter of mercury
    Exclusion criteria
    • RemovedPenetrating head injury, spine or spinal cord injury
    • RemovedCardiopulmonary resuscitation after injury or in need of blood transfusion due to active bleeding
    • RemovedPrior history of head trauma or stroke
    • RemovedMultiple injuries, with severity score of other parts>18
    • RemovedRhabdomyolysis, with blood creatine kinase (CK)>5000 international unit/L
    • RemovedInjury of aorta, carotid artery or vertebral artery
    • RemovedSerum creatinine (female)>1.2mg/dL (106μmol/L), serum creatinine (male)>1.5mg/dL (133μmol/L)
    • RemovedGlomerular filtration rate (eGFR) <60 milliliter/min
    • RemovedBody mass index (BMI) <18.5kg/m2 or >40kg/m2
    Interventions Arms added: all patients with moderate traumatic brain injury; arms removed: ICP monitoring group·conventional treatment group
    + 5 other changes: verification date, oversight details, description, design details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04900168
Lead sponsor
Tang-Du Hospital
Responsible party
Sponsor
First posted
May 25, 2021
Start date
Jun 1, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Zhihong Li, Doctor
Contact
409615390@qq.com
+81-029-84717821

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion